Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 115 participants.

Also called NCT06457685

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 115 participants (enrolled count) (from the registry)
Sponsor
Amplitude Vascular Systems, Inc. (from the registry)
Registry
  • NCT NCT06457685
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06457685. Allocation not applicable; no masking; primary purpose treatment. Start 2024-09-05 (actual); primary completion 2026-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial
Acronym
POWER PAD 2
Condition
Peripheral Arterial Disease (PAD)
Intervention (Device)
Pulse Intravascular Lithotripsy (Pulse IVL)
Lead sponsor
Amplitude Vascular Systems, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06457685
Content hash
cfdf07bd75e4e157645b42b674d88873a054aff755fe86878ccf77f08d054249